NEW YORK (GenomeWeb) — OpGen reported after the close of the market Tuesday a 26 percent drop in its third quarter revenues, citing lower sales of its legacy QuickFISH rapid pathogen diagnostic products.

For the three months ended Sept. 30, OpGen's revenues fell to $552,221 from $745,114 in the same period the year before, pulled down by the decline in QuickFISH revenues, and in line with previously disclosed estimates.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.